Collegium Pharmaceutical (COLL) Net Margin Growth (3y) (2019 - 2026)
Collegium Pharmaceutical (COLL) Net Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,620.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -98.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4,358.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,235.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -100.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4,252.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -404.00 |
| 10 | Collegium Pharmaceutical | 1.14 Bn | 853.50 Mn | 117.25 Mn | 1,953.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,953.00 |
| Dec 31, 2025 | 1,337.00 |
| Sep 30, 2025 | 1,469.00 |
| Jun 30, 2025 | 1,058.00 |
| Mar 31, 2025 | 1,696.00 |
| Dec 31, 2024 | 9,898.00 |
| Sep 30, 2024 | -435.00 |
| Jun 30, 2024 | -7,574.00 |
| Mar 31, 2024 | -6.00 |
| Dec 31, 2023 | 1,221.00 |
| Sep 30, 2023 | 84.00 |
| Jun 30, 2023 | -73.00 |
| Mar 31, 2023 | -1,263.00 |
| Dec 31, 2022 | -215.00 |
| Sep 30, 2022 | 873.00 |
| Jun 30, 2022 | 208.00 |
| Mar 31, 2022 | -259.00 |
| Dec 31, 2021 | -7,769.00 |
| Sep 30, 2021 | 21,008.00 |
| Jun 30, 2021 | 10,711.00 |